Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer
Crossref DOI link: https://doi.org/10.1007/s13304-015-0281-8
Published Online: 2015-02-22
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martellucci, Jacopo
Alemanno, Giovanni
Castiglione, Francesca
Bergamini, Carlo
Valeri, Andrea
Text and Data Mining valid from 2015-02-22